ULURU showcased and presented a paper at the recently concluded Symposium on Advances in Skin and Wound Care and Wound Healing Society, which was held in Dallas.
The company displayed seven scientific posters, including four clinical ones that showed the clinical benefits of Altrazeal. Three posters analyzed Altrazeal, which has exclusive properties that give clinical benefits.
A poster titled, ‘Preliminary Evaluation on the Application of a Powder Dressing in the Fixation and Treatment of Chronic Wounds Resulting from Trauma with Epidermal Separation’, written by Dr. Scott Gorenstein, Clinical Director, Wound Healing Center and Hyperbaric Medicine Winthrop-University Hospital, presented Altrazeal's clinical information on geriatric trauma treatment of wounds. The wounds were healed in 14 days.
The posters described the monitored release of actives and the potential to impact biofilms that hamper healing. The poster ‘Modification of Nanoparticle Aggregate Surfaces to Affect Bacterial Migration and Biofilm Formation, was written by Dr. John St. John, vice president of ULURU and showed it was possible to control biofilm creation by altering both the particle sizes and the materials used. The material composition of Altrazeal and nanoparticle size helped reduce biofilm creation.
Source: http://www.uluruinc.com